86 related articles for article (PubMed ID: 10591055)
1. The behaviour of aryl pyrrolines with monoamine oxidase.
Williams CH; Lawson J
Neurobiology (Bp); 1999; 7(2):225-33. PubMed ID: 10591055
[TBL] [Abstract][Full Text] [Related]
2. Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline.
Ogunrombi MO; Malan SF; Terre'Blanche G; Castagnoli K; Castagnoli N; Bergh JJ; Petzer JP
Life Sci; 2007 Jul; 81(6):458-67. PubMed ID: 17655878
[TBL] [Abstract][Full Text] [Related]
3. Deuterium isotope effects for the oxidation of 1-methyl-3-phenyl-3-pyrrolinyl analogues by monoamine oxidase B.
Pretorius A; Ogunrombi MO; Terre'blanche G; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2008 Oct; 16(19):8813-7. PubMed ID: 18799315
[TBL] [Abstract][Full Text] [Related]
4. Mechanism-based inhibition of monoamine oxidase by 3-aryl-Delta3-pyrrolines.
Williams CH; Lawson J
Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):63-7. PubMed ID: 9806885
[TBL] [Abstract][Full Text] [Related]
5. Interactions of 1-methyl-3-phenylpyrrolidine and 3-methyl-1-phenyl-3-azabicyclo[3.1.0]hexane with monoamine oxidase B.
Pretorius A; Ogunrombi MO; Fourie H; Terre'blanche G; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2010 Jun; 18(11):4111-8. PubMed ID: 20451395
[TBL] [Abstract][Full Text] [Related]
6. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
Inoue H; Castagnoli K; Van Der Schyf C; Mabic S; Igarashi K; Castagnoli N
J Pharmacol Exp Ther; 1999 Nov; 291(2):856-64. PubMed ID: 10525109
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships in the inhibition of monoamine oxidase B by 1-methyl-3-phenylpyrroles.
Ogunrombi MO; Malan SF; Terre'blanche G; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2008 Mar; 16(5):2463-72. PubMed ID: 18065227
[TBL] [Abstract][Full Text] [Related]
8. Involvement of hepatic aldehyde oxidase in conversion of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) to 1-methyl-4-phenyl-5,6-dihydro-2-pyridone.
Yoshihara S; Ohta S
Arch Biochem Biophys; 1998 Dec; 360(1):93-8. PubMed ID: 9826433
[TBL] [Abstract][Full Text] [Related]
9. Comparative aromatic hydroxylation and N-demethylation of MPTP neurotoxin and its analogs, N-methylated beta-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6.
Herraiz T; Guillén H; Arán VJ; Idle JR; Gonzalez FJ
Toxicol Appl Pharmacol; 2006 Nov; 216(3):387-98. PubMed ID: 16870220
[TBL] [Abstract][Full Text] [Related]
10. Some peculiar aspects of monoamine oxidase inhibition.
Ramadan ZB; Dostert P; Tipton KF
Neurobiology (Bp); 1999; 7(2):159-74. PubMed ID: 10591050
[TBL] [Abstract][Full Text] [Related]
11. 3-pyrrolines are mechanism-based inactivators of the quinone-dependent amine oxidases but only substrates of the flavin-dependent amine oxidases.
Lee Y; Ling KQ; Lu X; Silverman RB; Shepard EM; Dooley DM; Sayre LM
J Am Chem Soc; 2002 Oct; 124(41):12135-43. PubMed ID: 12371853
[TBL] [Abstract][Full Text] [Related]
12. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Muralikrishnan D; Samantaray S; Mohanakumar KP
Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
[TBL] [Abstract][Full Text] [Related]
13. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833
[TBL] [Abstract][Full Text] [Related]
14. Simple, potent, and selective pyrrole inhibitors of monoamine oxidase types A and B.
Silvestri R; La Regina G; De Martino G; Artico M; Befani O; Palumbo M; Agostinelli E; Turini P
J Med Chem; 2003 Mar; 46(6):917-20. PubMed ID: 12620068
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
[TBL] [Abstract][Full Text] [Related]
16. Analysis of monoamine oxidase enzymatic activity by reversed-phase high performance liquid chromatography and inhibition by beta-carboline alkaloids occurring in foods and plants.
Herraiz T; Chaparro C
J Chromatogr A; 2006 Jul; 1120(1-2):237-43. PubMed ID: 16386263
[TBL] [Abstract][Full Text] [Related]
17. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
Alves E; Summavielle T; Alves CJ; Custódio JB; Fernandes E; de Lourdes Bastos M; Tavares MA; Carvalho F
Addict Biol; 2009 Apr; 14(2):185-93. PubMed ID: 19076925
[TBL] [Abstract][Full Text] [Related]
18. Tyramine and monoamine oxidase inhibitors as modulators of the mitochondrial membrane permeability transition.
Marcocci L; De Marchi U; Salvi M; Milella ZG; Nocera S; Agostinelli E; Mondovi B; Toninello A
J Membr Biol; 2002 Jul; 188(1):23-31. PubMed ID: 12172644
[TBL] [Abstract][Full Text] [Related]
19. Distinct structure and activity of monoamine oxidase in the brain of zebrafish (Danio rerio).
Anichtchik O; Sallinen V; Peitsaro N; Panula P
J Comp Neurol; 2006 Oct; 498(5):593-610. PubMed ID: 16917825
[TBL] [Abstract][Full Text] [Related]
20. 1-Methyl-3-pyrrolines and 2-methylisoindolines: new classes of cyclic tertiary amine monoamine oxidase B substrates.
Wang YX; Mabic S; Castagnoli N
Bioorg Med Chem; 1998 Feb; 6(2):143-9. PubMed ID: 9547937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
